Bleeding Disorder of Unknown Cause

1

Review clinical trials related to Bleeding Disorder of Unknown Cause. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Bleeding Disorder of Unknown Cause in the Netherlands

The purpose of the Bleeding Disorder of Unknown Cause in the Netherlands study (BDUC-iN) is to learn more about unexplained bleeding in individuals with a bleeding disorder of unknown cause (BDUC). The study aims to better understand why these individuals have increased bleeding and how it affects their health and daily life. The main questions of this study are: 1. What are the mechanisms underlying the bleeding tendency in BDUC? 2. How do bleeding symptoms affect patients' daily functioning and overall health-related quality of life? 3. How is care delivered to individuals with BDUC, and how can this be improved? Participants with increased bleeding tendency who remain undiagnosed after standard coagulation testing and are consequently classified as having BDUC will be enrolled across the Hemophilia treatment centers in the Netherlands. Participants will undergo blood sampling for advanced hemostasis testing and genetic analysis. In addition, participants will complete validated questionnaires to assess bleeding symptoms and health-related quality of life. Participants will be followed longitudinally to evaluate how bleeding symptoms affect daily activities, medical procedures, and overall health-related quality of life.

Participants needed: 500
Trial details
Age: 12+Biological sex: AllType: ObservationalSponsor: Maastricht University Medical CenterUpdated: Apr 27, 2026Locations: 8Duration: 10 Years
Eligibility criteria

Referred to a (pediatric) hemostasis specialist for evaluation of bleeding tende... [+7]

Use of medication interfering with laboratory hemostasis tests which cannot be s... [+4]